X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (61144) 61144
Publication (4561) 4561
Newsletter (1239) 1239
Book Review (1103) 1103
Newspaper Article (1082) 1082
Book Chapter (395) 395
Magazine Article (195) 195
Conference Proceeding (132) 132
Book / eBook (62) 62
Dissertation (58) 58
Transcript (54) 54
Trade Publication Article (36) 36
Reference (31) 31
Government Document (6) 6
Web Resource (6) 6
Data Set (5) 5
Paper (1) 1
Presentation (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29379) 29379
animals (29377) 29377
male (25972) 25972
serotonin (21128) 21128
female (15986) 15986
index medicus (15971) 15971
rats (15747) 15747
pharmacology & pharmacy (14142) 14142
neurosciences (13183) 13183
psychiatry (11083) 11083
adult (9045) 9045
serotonin - metabolism (8730) 8730
middle aged (6897) 6897
antidepressants (6771) 6771
serotonin uptake inhibitors - therapeutic use (6041) 6041
mice (6031) 6031
serotonin - pharmacology (5831) 5831
dose-response relationship, drug (5809) 5809
depression (5457) 5457
clinical neurology (4919) 4919
antidepressive agents - therapeutic use (4862) 4862
dopamine (4856) 4856
rats, sprague-dawley (4185) 4185
aged (4150) 4150
brain (4015) 4015
treatment outcome (3958) 3958
brain - metabolism (3903) 3903
double-blind (3853) 3853
serotonin reuptake inhibitors (3721) 3721
serotonin uptake inhibitors (3691) 3691
in vitro techniques (3654) 3654
serotonin antagonists - pharmacology (3644) 3644
serotonin - physiology (3565) 3565
research (3550) 3550
fluoxetine (3478) 3478
time factors (3375) 3375
receptors, serotonin - drug effects (3309) 3309
rats, wistar (3291) 3291
5-ht (3265) 3265
antidepressive agents - pharmacology (3185) 3185
serotonin uptake inhibitors - adverse effects (3151) 3151
adolescent (3099) 3099
analysis (3065) 3065
depressive disorder - drug therapy (3031) 3031
receptors (3006) 3006
brain - drug effects (2999) 2999
dopamine - metabolism (2948) 2948
major depression (2802) 2802
serotonin uptake inhibitors - pharmacology (2719) 2719
drug therapy (2717) 2717
depression, mental (2714) 2714
drugs (2669) 2669
drug interactions (2497) 2497
anxiety (2483) 2483
rat (2476) 2476
behavior, animal - drug effects (2413) 2413
biochemistry & molecular biology (2387) 2387
receptors, serotonin - metabolism (2378) 2378
disease models, animal (2354) 2354
serotonin receptor agonists - pharmacology (2340) 2340
rats, inbred strains (2303) 2303
schizophrenia (2292) 2292
double-blind method (2282) 2282
phenols (2274) 2274
depression - drug therapy (2239) 2239
risk factors (2179) 2179
norepinephrine - metabolism (2169) 2169
antidepressive agents - adverse effects (2151) 2151
pharmacology (2149) 2149
5-hydroxytryptamine (2143) 2143
care and treatment (2134) 2134
article (2133) 2133
depressive disorder, major - drug therapy (2084) 2084
major depressive disorder (2019) 2019
neurons (2014) 2014
motor activity - drug effects (1975) 1975
antipsychotic agents - therapeutic use (1911) 1911
rat-brain (1890) 1890
drug therapy, combination (1860) 1860
antidepressant (1854) 1854
receptor (1853) 1853
piperazines - pharmacology (1806) 1806
norepinephrine (1768) 1768
neurology (1740) 1740
physiology (1737) 1737
efficacy (1730) 1730
neurotransmitter agents - metabolism (1708) 1708
health aspects (1701) 1701
paroxetine (1662) 1662
medicine, general & internal (1660) 1660
medicine & public health (1629) 1629
behavioral sciences (1626) 1626
child (1600) 1600
serotonin antagonists - therapeutic use (1575) 1575
pregnancy (1573) 1573
behavior (1566) 1566
receptors, serotonin - physiology (1557) 1557
physiological aspects (1538) 1538
rodents (1514) 1514
neurons - drug effects (1492) 1492
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (45) 45
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
UofT at Mississauga - Stacks (5) 5
Online Resources - Online (4) 4
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
University College (Laidlaw) - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Gerstein Science - Missing (1) 1
Knox College (Caven) - Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Patient Education (1) 1
Scarborough Hospital - General (1) 1
Toronto East General Hospital - Chaplain Dept. (1) 1
UTL at Downsview - May be requested (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (60783) 60783
Russian (629) 629
German (602) 602
French (587) 587
Japanese (425) 425
Italian (225) 225
Spanish (197) 197
Polish (106) 106
Chinese (99) 99
Swedish (81) 81
Danish (73) 73
Dutch (67) 67
Norwegian (57) 57
Hungarian (56) 56
Portuguese (35) 35
Finnish (21) 21
Turkish (21) 21
Korean (20) 20
Czech (16) 16
Ukrainian (9) 9
Serbian (7) 7
Romanian (6) 6
Bulgarian (5) 5
Hebrew (4) 4
Croatian (3) 3
Lithuanian (2) 2
Afrikaans (1) 1
Arabic (1) 1
Bosnian (1) 1
Greek (1) 1
Icelandic (1) 1
Persian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Life Sciences, ISSN 0024-3205, 2005, Volume 78, Issue 5, pp. 442 - 453
The marine environment produces natural products from a variety of structural classes exhibiting activity against numerous disease targets. Historically marine... 
Indole alkaloids | Bioactive marine natural products | New drug leads | TUNICATE EUDISTOMA-OLIVACEUM | MISCELLANEOUS MECHANISMS | MEDICINE, RESEARCH & EXPERIMENTAL | indole alkaloids | BETA-CARBOLINES | BIS-INDOLE | BRYOZOAN FLUSTRA-FOLIACEA | NERVOUS SYSTEMS | ANTIVIRAL ACTIVITIES | new drug leads | ORINA SP | SPONGE | PHARMACOLOGY & PHARMACY | DEEP-WATER | bioactive marine natural products | Anti-Infective Agents - isolation & purification | Serotonin Agents - isolation & purification | Anti-Infective Agents - pharmacology | Humans | Parasitic Diseases - drug therapy | Neoplasms - prevention & control | Neuroprotective Agents - pharmacology | Antineoplastic Agents - isolation & purification | Anti-Infective Agents - chemistry | Enzyme Inhibitors - chemistry | Antiparasitic Agents - isolation & purification | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Alkaloids - pharmacology | Neuroprotective Agents - chemistry | Enzyme Inhibitors - pharmacology | Nervous System Diseases - drug therapy | Antineoplastic Agents - chemistry | Enzyme Inhibitors - isolation & purification | Neoplasms - drug therapy | Biological Products - chemistry | Nervous System Diseases - prevention & control | Animals | Serotonin Agents - chemistry | Serotonin Agents - pharmacology | Neuroprotective Agents - isolation & purification | Antiparasitic Agents - pharmacology | Alkaloids - therapeutic use | Indoles - therapeutic use | Indoles - chemistry | Alkaloids - chemistry | Antiparasitic Agents - chemistry | Antimitotic agents | Alkaloids | Care and treatment | Antineoplastic agents | Cancer
Journal Article
Journal Article
Drugs, ISSN 0012-6667, 12/2011, Volume 71, Issue 17, pp. 2247 - 2255
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2009, Issue 2, p. CD006532
Journal Article
British Journal of Nutrition, ISSN 0007-1145, 01/2015, Volume 113, Issue 2, pp. 350 - 365
Common pharmacological treatments of mood disorders aim to modulate serotonergic neurotransmission and enhance serotonin levels in the brain. Brain serotonin... 
Well-being | Serotonin | LumiVida | Tryptophan | Depression | Cognition | Emotion | FEMALE VOLUNTEERS | PLASMA TRYPTOPHAN | COGNITIVE PERFORMANCE | DEPRESSED-PATIENTS | HEALTHY-SUBJECTS | LumiVida (TM) | ALPHA-LACTALBUMIN INCREASES | NEUTRAL AMINO-ACIDS | VULNERABLE SUBJECTS | NUTRITION & DIETETICS | MOOD | Protein Hydrolysates - metabolism | Stress, Psychological - prevention & control | Nootropic Agents - metabolism | Humans | Middle Aged | Reaction Time | Antidepressive Agents - metabolism | Tryptophan - metabolism | Cognitive Dysfunction - prevention & control | Mental Fatigue - metabolism | Sleep Wake Disorders - metabolism | Depression - metabolism | Egg Proteins, Dietary - adverse effects | Psychiatric Status Rating Scales | Mental Fatigue - prevention & control | Tryptophan - blood | Stress, Psychological - metabolism | Egg Proteins, Dietary - therapeutic use | Female | Dietary Supplements - adverse effects | Beverages | Egg Proteins, Dietary - metabolism | Antidepressive Agents - blood | Serotonin Agents - therapeutic use | Protein Hydrolysates - therapeutic use | Double-Blind Method | Stress, Psychological - blood | Cognitive Dysfunction - metabolism | Nootropic Agents - therapeutic use | Cognitive Dysfunction - blood | Nootropic Agents - blood | Nootropic Agents - adverse effects | Protein Hydrolysates - adverse effects | Serotonin Agents - metabolism | Serotonin Agents - adverse effects | Antidepressive Agents - therapeutic use | Mental Fatigue - blood | Depression - prevention & control | Energy Metabolism | Sleep Wake Disorders - blood | Sleep Wake Disorders - prevention & control | Tryptophan - adverse effects | Aged | Serotonin Agents - blood | Antidepressive Agents - adverse effects | Tryptophan - therapeutic use | Cohort Studies | Depression - blood | Amino acids | Emotional disorders | Cognition & reasoning | Dietary supplements
Journal Article